List view / Grid view
13 February 2015 | By Public Health England
Public Health England’s latest report shows a high number of scarlet fever notifications across England, with a total of 1265 new cases reported in the first 6 weeks of 2015...
13 February 2015 | By PatientView
An independent study by PatientView...
13 February 2015 | By Moberg Pharma
Moberg Pharma AB announced that it shipped opening orders of its new line extension, Kerasal® Complete Care in Walgreens, the #1 drug chain in the U.S., with additional retailers expected to follow...
Lonza, a global leader in biological and cell therapy manufacturing and TiGenix, an advanced biopharmaceutical company focused on developing and commercialising novel therapeutics from allogeneic expanded adipose-derived stem cells (eASCs) in inflammatory and autoimmune diseases, announced today an agreement for the supply of TiGenix's eASC product, Cx601.
12 February 2015 | By Equiniti 360 Clinical
The vast majority of patients are happy with the care they receive from their doctors, according to analysis by one of the UK’s largest providers of medical revalidation, Equiniti 360 Clinical, with over 98% saying they are satisfied with the overall experience provided...
12 February 2015 | By KU Leuven
Writing in the journal EBioMedicine, researchers at KU Leuven’s Laboratory for Clinical and Epidemiological Virology now report a recombinant form of HIV observed in patients in Cuba that makes this transition much faster...
11 February 2015 | By Eli Lilly & Company
College freshmen face tremendous pressure, often trying to adjust to tough academic standards while living away from home for the first time...
Amazing opportunities come along with prototyping technologies, and three-dimensional (3D) printing is gaining momentum across various industries, from printing a mobile phone cover to reconstructing human organs. Emerging as a technology of choice for a wide range of applications, 3D printing is expected to increase its market share rapidly to…
11 February 2015 | By GlobalData
Following a less than flattering financial performance in 2014, GlaxoSmithKline plc is realigning its operating structure with its corporate objectives and cashing in on its assets in the process, as the company seeks to drive up external investments and deliver stronger shareholder returns in the long term, says an analyst…
10 February 2015 | By kdm communications
Re-Pharm, an early-stage drug discovery and development company based on the principles of compound re-profiling, is pleased to announce the identification of RP0217 as an effective new anti-inflammatory agent...
10 February 2015 | By kdm communications
Microfluidics specialist Dolomite has created a low cost kit aimed at educational initiatives or those new to microfluidics...
10 February 2015 | By Boehringer Ingelheim
Boehringer Ingelheim, a research-based, global pharmaceutical company, and VTU Technology, a leading contract research and development company, announced today the renewal of their global Pichia pastoris technology collaboration agreement...
10 February 2015 | By Doctors of the World
Doctors of the World - Médecins du Monde is today filing its opposition to the patent granted for sofosbuvir (Sovaldi) with the European Patent Office...
10 February 2015 | By The Institute of Cancer Research
Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London, said: “We’re very disappointed that Scottish men with prostate cancer will miss out on the chance to have abiraterone much earlier in their course of treatment as a result of this decision..."
9 February 2015 | By Pharmaceutical Licensing Group
Pharmaceutical Licensing Group has announced the results of its 8th Annual Awards for excellence in business development which were given at its AGM on 5th February 2015...
